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The basal ganglia, said
Kinnear-Wilson in the 1920s, have all
the clarity of a dark basement. And
so it has remained for the better part
of a century. There are now major
new ideas about what these deep-
lying structures in the forebrain may
be doing. Lesions of the basal
ganglia lead to devastating motor
disorders, including Parkinson’s
disease and Huntington’s disease. In
addition, the basal ganglia have been
implicated in a range of
neuropsychiatric disorders, and basal
ganglia function is disrupted in
addictive states. The basal ganglia
are also thought to have a major role
in learning and memory. How can
these structures have so many
functions? Or is it possible that there
is some common theme to these
apparently disparate functions?
The position of the basal ganglia
in the circuitry of the brain gives a
clue to their function (Figure 1).
They are the largest subcortical
structures in the human forebrain.
The basal ganglia receive inputs
from the neocortex and, by way of
their output nuclei, the basal ganglia
nuclei project massively to thalamic
nuclei, which in turn project to the
frontal cortex. This anatomy means
the basal ganglia are in a prime
position to influence the executive
functions of the forebrain, such as
planning for movement and even
cognitive behaviors. In addition to
this tight linkage with the frontal
cortex, the basal ganglia send outputs
to brainstem nuclei involved in
motor control, including the superior
colliculus, which controls axial
orientation and saccadic eye
movements.
The basal ganglia consist of
several different nuclei (Figure 1),
and each of these is profoundly
important clinically. The striatum
(made up of the caudate nucleus and
the putamen) receives most of the
cortical input to the basal ganglia.
Degeneration of neurons in the
striatum leads to Huntington’s
disease and related hyperkinetic
disorders. The pallidum (consisting
of external and internal segments)
receives most of the output of the
striatum. The pallidum is the site of
therapeutic lesion (pallidotomy) and
deep-brain stimulation procedures
used to relieve Parkinson’s disease.
The subthalamic nucleus is a key
structure controlling pallidal
function, and is an increasingly
favored site for deep-brain
stimulation in the treatment of
Parkinson’s disease. The substantia
nigra (with a dopamine-containing
region, the pars compacta, and a
second region, the pars reticulata) is
critical to basal ganglia function.
Dopamine-synthesizing neurons in
the substantia nigra pars compacta
degenerate in Parkinson’s disease
and related parkinsonian disorders.
The pedunculopontine nucleus of
the brainstem is also associated with
the basal ganglia and affects function
in several nuclei of basal ganglia
circuits, most notably the substantia
nigra pars compacta.
Motor system disorders
The leading model for motor
disorders such as Parkinson’s and
Huntington’s diseases is that the
basal ganglia have distinct pathways
that compete with each other
functionally to release movement
(the direct pathway) or to inhibit
movement (the indirect pathway)
(Figure 2). The competing pathways
act like the brake and accelerator in a
car. The brake–accelerator model
suggests that release (disinhibition)
of the thalamus by the direct
pathway is opposed by the indirect
pathway, which inhibits the thalamus
via the additional, excitatory,
subthalamic projection to the
internal pallidum.
In the simplest view, the poverty
of movement in Parkinson’s disease
results from over-activity of the
indirect pathway, whereas excess
movement in disorders such as
Huntington’s disease represent
over-activity of the direct pathway.
There are problems with this model,
and there is also controversy about
how the dopamine-containing inputs
from the substantia nigra affect this
system. One view is that D1-class
dopamine receptors are mainly
expressed on direct pathway striatal
neurons and excite this pathway,
whereas D2-class dopamine
receptors are expressed on indirect
pathway striatal neurons and inhibit
this pathway. Coexpression of these
receptors has also been claimed,
however. It has been proposed that
antagonism between the direct and
indirect pathways helps select
intended movements by suppressing
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Figure 1
The basic anatomy of the brain showing the
major regions within the basal ganglia: the
striatum (blue), which is made up of the
caudate nucleus and the putamen; the
pallidum (pink), which is made up of outer
and inner segments; the subthalamic nucleus
(green); and the substantia nigra (yellow).
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unintended ones and promoting
desired movements — a sculpting
process for movement control.
An interesting recent
development is the discovery that
the torsion dystonia (DYT1) gene —
a mutant form of the gene encoding
torsin A, a chaperone protein
associated with early onset dystonia
— is strongly expressed in
dopamine-containing neurons of the
substantia nigra pars compacta.
Defects in the dopamine system
occurring at different ages may lead
to dystonia or to Parkinson’s disease.
Mutations in several genes have now
been associated with hereditary
forms of parkinsonism. These new
findings should significantly help in
understanding the cellular events
underlying the neuropathology of
these disorders.
Neuropsychiatric disorders
Neuropsychiatric symptoms in
Parkinson’s and Huntington’s
diseases have, until recently, mostly
been interpreted as co-existing or
secondary symptoms, but increasing
evidence suggests that they may be
primary symptoms. Functional
imaging methods have opened up a
more direct way of detecting basal
ganglia dysfunction in
neuropsychiatric disorders, as these
methods allow detection of
metabolic brain abnormalities even
where there is no evident large-scale
degeneration (as is true for most
neuropsychiatric disorders).
Metabolic abnormalities in the
basal ganglia have been observed with
PET (positron emission tomography)
and fMRI (functional magnetic
resonance imaging) brain imaging in
patients suffering
obsessive–compulsive disorder
(OCD) and Tourette syndrome. In
OCD, such studies have
demonstrated abnormal activity in the
caudate nucleus, in the orbitofrontal
cortex and in the anterior cingulate
cortex. These structures, together
with their thalamic connections, are
thought to form cortico-basal ganglia
loops that are overactive or
underactive when symptoms are
evident. In some patients, drug
treatment and behavioral therapy can
help attenuate the abnormal activity.
Neuroimaging studies of Tourette
syndrome patients also show
abnormal activity in the striatum,
especially in the putamen, which
includes the striatal regions receiving
input from the sensory–motor cortex.
Striking instances of compulsive
behaviors have also been found in
patients with focal lesions in the
striatum or pallidum.
Brain mapping performed during
deep-brain stimulation procedures
suggests that the basal ganglia may
directly contribute to neuropsychiatric
syndromes. Sudden and severe
depressive episodes have been
induced by stimulation in the
substantia nigra, followed by a
euphoric rebound when the
stimulation stops. This supports
evidence from imaging experiments
suggesting abnormal metabolic
activity in the caudate nucleus
during depression.
A large series of studies has
implicated the ventral striatum
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Figure 2
The brake–accelerator model for basal ganglia
motor disorders. (a) The direct pathway
(leading to release of movement) consists of
two successive GABAergic connections, from
the striatum to the internal pallidum and from
the internal pallidum to the thalamus. This flow
diagram suggests that excitatory (glutamate;
Glu) inputs from the neocortex to the striatum
would disinhibit thalamic neurons. Dopamine
modulates the system mainly in the striatum,
where it activates D1-class and D2-class
dopamine receptors. (b) In the indirect
pathway (leading to inhibition of movement),
there is an extra step after the external
pallidum, so that the subthalamic nucleus
excites the internal pallidum. (c) Balance is
achieved when these antagonistic systems are
combined under normal circumstances.
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(including the nucleus accumbens),
the ventral pallidum and the
corresponding medial parts of the
dopamine-containing cell groups of
the midbrain (the ventral tegmental
area) in the pathogenesis of
schizophrenia. Whether dorsal striatal
regions (caudate nucleus and
putamen) are also involved is not
clear. The fact that the prefrontal
cortex is implicated in this disorder,
and that the basal ganglia pathways
linked to the caudate nucleus direct
their outputs to prefrontal areas, raises
the possibility that basal ganglia
malfunction occurs in schizophrenia.
Cortico-basal ganglia loops
The anatomy of basal ganglia
connections suggests that, at least in
part, these structures operate as part
of recurrent circuits (loops) with the
cerebral cortex. Broad subdivisions
exist within these cortico-basal
ganglia loops, suggesting that
different loops operate in relation to
different types of cortical function
(for example, oculomotor versus
working memory circuits). Not all
cortical connections of the basal
ganglia form these loops, however,
and patterns of convergence and
divergence within individual circuits
may be crucial to their function. For
example, this within-loop sorting
may be a way to select particular
outputs, and in turn to select
particular behavioral actions.
Habit learning
The striatum is part of the learning
and memory machinery of the brain.
Experimental evidence suggests that
the striatum is involved in the type
of procedural or implicit learning
resulting in automatized responses,
roughly equivalent to habits. This
function is contrasted with
hippocampus-based learning, which
builds memories that are dependent
on particular cues in the
environment. This idea has been
reinforced by studies of patients with
Parkinson’s and Huntington’s
diseases. In addition, my co-workers
and I have found large-scale changes
in the ensemble activity of neurons
in the sensorimotor striatum as rats
learn a procedural task. If lesions are
made in this striatal region after the
period of learning, the animals have
difficulty remembering how to do
the task. These results suggest that
the learning-related changes in
striatal activity (probably
accompanied by, or even resulting
from, changes elsewhere in cortico-
basal ganglia circuits) are necessary
for the maintenance of new habits.
The homologues of the basal ganglia
in birds have been implicated in the
highly stereotyped behavioral
patterns developed in song learning.
This suggests that the learning and
memory functions of the basal
ganglia may be highly conserved.
One important signaling
mechanism for learning based in the
basal ganglia occurs in the
dopamine-containing neurons of the
midbrain and their projections into
the striatum (and into the neocortex).
Inputs to the striatum from the
dopamine-containing neurons have
been suggested to deliver
reward-predictive signals to the
striatum. Interestingly, when rats are
treated with cocaine or
amphetamine, there is heightened
activation of striosomes, one of the
two tissue compartments of the
striatum, and a proportionate
increase in stereotyped behavior that
occurs when the drugs are given
repeatedly. The ventral striatum is
implicated in the addictive changes
that occur with drug use. Both
striosomes and the ventral striatum
project back to the
dopamine-containing nuclei of the
brainstem, and may influence these
drug-related behavioral changes.
This suggests that loops
interconnecting the cortex, the
striatum and the
dopamine-containing cell groups in
the midbrain are critical for
reward-based learning and memory.
A common theme?
The learning and memory functions
of the basal ganglia may be related to
their importance in extrapyramidal
motor disorders and neuropsychiatric
disorders. In a forward model of the
basal ganglia, the striatum and other
basal ganglia nuclei would receive
incoming signals about the current
status of events (in action or mental
space), as well as signals predicting
future events. The cortico-basal
ganglia loops running through the
striatum and basal ganglia circuits
would sort and combine such signals,
and then influence cortical and
subcortical networks responsible for
the production of motor or cognitive
activity. Under conditions of circuit
dysfunction, at one extreme
excessive and repetitive actions or
thoughts could result, and at the
other extreme poverty of movement
or thought could be the result.
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